Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.
OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation
Published 15 hours ago
Source: techcrunch.com
Categories
Biotech & HealthAIventure capitalOpenAIIn Briefartificial intelligenceChai Discovery
Related Articles from techcrunch.com
7 minutes ago
India’s Digantara raises $50M for space-based missile defence tech
12 minutes ago
Databricks raises $4B at $134B valuation as its AI business heats up
51 minutes ago
Adobe Firefly now supports prompt-based video editing, adds more third-party models
1 hour ago
Nuclear startup Last Energy raises $100M for its steel-encased micro reactor
2 hours ago
Everbloom built an AI to turn chicken feathers into cashmere
3 hours ago